Table 2
Period-based cumulative relative survival ratios (RSR) derived using expected survival probabilities adjusted for cancer mortality, and differences from RSRs derived using unadjusted probabilities, by age group and sex, selected cancers, Canada excluding Quebec, 2006 to 2008

Table 2
Period-based cumulative relative survival ratios (RSR) derived using expected survival probabilities adjusted for cancer mortality, and differences from RSRs derived using unadjusted probabilities, by age group and sex, selected cancers, Canada excluding Quebec, 2006 to 2008
Table summary
This table displays the results of Period-based cumulative relative survival ratios (RSR) derived using expected survival probabilities adjusted for cancer mortality. The information is grouped by Cancer,
age group, sex (appearing as row headers), RSR using adjusted life tables (%), Overestimate of RSR using unadjusted life tables (% units) and Survival duration (appearing as column headers).
Cancer,
age group, sex
RSR using adjusted life tables (%) Overestimate of RSR using unadjusted life tables (% units)
Survival duration Survival duration
1-year 5-year 10-year 1-year 5-year 10-year
All cancers  
15 to 99 76.3 60.9 54.3 0.6 2.4 4.6
15 to 44 92.9 82.8 78.1 0.0 0.1 0.4
45 to 54 86.3 72.2 66.2 0.1 0.5 1.3
55 to 64 82.3 67.1 60.2 0.3 1.4 3.2
65 to 74 76.1 59.9 51.8 0.6 2.9 6.2
75 to 99 62.6 45.1 38.8 1.0 4.1 8.1
Male 75.2 59.5 52.4 0.7 3.0 5.9
Female 77.7 62.4 56.3 0.4 1.7 3.4
Colorectal  
15 to 99 82.2 64.0 59.7 0.1 0.4 0.8
15 to 54 89.8 67.4 61.2 0.0 0.0 0.1
55 to 64 88.3 68.6 62.8 0.0 0.2 0.4
65 to 74 84.7 66.9 61.3 0.1 0.4 0.8
75 to 99 73.9 58.2 58.0 0.2 0.7 1.6
Male 82.9 63.5 58.4 0.1 0.4 0.9
Female 81.3 64.7 61.2 0.1 0.3 0.7
Lung and bronchus  
15 to 99 40.3 16.9 12.4 0.1 0.2 0.3
15 to 54 49.5 23.4 19.1 0.0 0.0 0.1
55 to 64 45.2 19.9 15.0 0.1 0.1 0.3
65 to 74 41.9 17.5 11.9 0.1 0.3 0.4
75 to 99 32.9 12.2 9.1 0.1 0.2 0.4
Male 36.4 14.2 10.5 0.1 0.2 0.4
Female 44.6 19.9 14.6 0.1 0.2 0.3
Female breast  
15 to 99 96.8 87.5 81.6 0.1 0.3 0.6
15 to 54 98.3 88.9 81.9 0.0 0.1 0.2
55 to 64 97.7 89.2 83.4 0.1 0.3 0.5
65 to 74 97.2 89.0 83.8 0.1 0.4 0.9
75 to 99 92.8 81.6 77.3 0.1 0.7 1.4
Prostate  
15 to 99 98.1 95.1 92.1 0.1 0.6 1.4
15 to 54 99.6 96.9 95.2 0.0 0.0 0.1
55 to 64 99.6 97.8 95.8 0.0 0.1 0.3
65 to 74 99.6 98.0 95.9 0.1 0.4 1.3
75 to 99 93.7 86.7 79.6 0.3 1.5 3.5
Bladder  
15 to 99 85.3 71.1 64.8 0.0 0.2 0.3
15 to 54 92.5 82.9 79.5 0.0 0.0 0.0
55 to 64 91.6 80.6 74.6 0.0 0.0 0.1
65 to 74 87.9 73.8 66.3 0.0 0.1 0.3
75 to 99 79.3 61.9 54.6 0.1 0.3 0.6
Male 86.6 72.4 65.4 0.0 0.2 0.4
Female 81.3 67.4 62.7 0.0 0.1 0.1
Non-Hodgkin lymphoma  
15 to 99 79.0 66.3 58.9 0.0 0.1 0.2
15 to 54 90.7 81.2 74.6 0.0 0.0 0.0
55 to 64 86.8 74.4 65.1 0.0 0.1 0.1
65 to 74 80.1 64.7 54.2 0.0 0.1 0.2
75 to 99 63.1 48.3 44.3 0.0 0.2 0.3
Male 78.4 64.5 56.3 0.0 0.1 0.2
Female 79.7 68.3 61.8 0.0 0.1 0.1
Leukemia  
15 to 99 72.1 59.2 50.0 0.0 0.1 0.1
15 to 54 85.9 72.7 66.1 0.0 0.0 0.0
55 to 64 83.7 70.0 60.6 0.0 0.0 0.1
65 to 74 71.7 60.2 45.0 0.0 0.1 0.2
75 to 99 56.3 42.4 35.2 0.0 0.1 0.3
Male 73.7 59.5 49.9 0.0 0.1 0.2
Female 69.8 58.7 50.2 0.0 0.1 0.1
Date modified: